Psychosocial Impact of Control-IQ Technology in Pediatric Users with Type 1 Diabetes: Real-World Insights from the United States

Harsimran Singh PhD,* Michelle Manning MA,* Molly McElwee Malloy RN, CDCES,* Alexandra Constantin PhD*, Steph Habif EdD, MS*


To examine the impact of Control-IQ® technology on psychosocial outcomes including sleep quality in adolescents with type 1 diabetes (T1D).


We analyzed psychosocial outcomes in 14- to 17-year-old T1D adolescents who had been using Control-IQ technology on the t:slim X2™ insulin pump in a real-world setting for at least three weeks.


A positive correlation was observed between participants’ emotional well-being and quality of sleep. While device-related satisfaction (DS) and quality of sleep were positively correlated, diabetes-related impact (DI) and quality of sleep were negatively correlated. DI and DS independently predicted HbA1c.


Quality of sleep is an important factor determining both device‑related satisfaction and quality of life in T1D adolescents.